Hyperfine, Inc.NASDAQ: HYPR

Hyperfine to Participate in Jefferies London and BTIG Tech-Enabled Healthcare Conferences

· Issued by Hyperfine, Inc. via Business Wire

Summary by 6ix AI

Hyperfine, Inc., which makes the Swoop portable MRI (magnetic resonance imaging) system for brain imaging, said management will host investor meetings at two healthcare conferences in November 2026.

Key details

  • Jefferies Global Healthcare Conference in London: in-person meetings on Wednesday, November 18 and Thursday, November 19, 2026.
  • U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum 2026: virtual meetings on Monday, November 23, 2026.
  • Investors can request one-on-one meetings with management through their Jefferies or BTIG representative or Hyperfine's investor contact.

6ix AI wrote this summary from the release below and checked it against the release.

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that management will host investor meetings at two healthcare conferences in November.

UPCOMING CONFERENCES

  • 2026 Jefferies Global Healthcare Conference in London - Wednesday, November 18 and Thursday, November 19, 2026. Management will be hosting in-person meetings.
  • U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum 2026 - Monday, November 23, 2026. Management will be hosting virtual meetings.

To schedule a one-on-one meeting with management, please reach out to your Jefferies or BTIG representative, or the investor contact below.

About the Swoop® Portable MRI Systems
The Swoop® Portable MR Imaging® Systems are U.S. Food and Drug Administration (FDA) cleared for brain imaging of patients of all ages. They are portable, ultra-low-field magnetic resonance imaging devices for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.

About Hyperfine, Inc.
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. For more information, visit HyperfineMRI.com.

The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc. The Swoop logo, Optive AI logo, and Optive AI are trademarks of Hyperfine, Inc.

View original source (Business Wire)Hyperfine, Inc. on 6ix

Story so far

Earlier from Hyperfine

Later from Hyperfine

All Hyperfine news releases